Anna Wakefield

Anna Wakefield has a diverse work experience, starting in 2012 as a Fellow at Balloon Ventures. Anna then worked as a Fellow at The Challenge Network in 2013. In the same year, they joined Doremus as a Planner, where they were part of the innovation team designing social network analysis software. Anna represented the agency as an Omnicom 'Emerging Star' in 2015.

In 2014, Anna became a Non Executive Director at Epic CIC, a role they held until 2017. Anna then joined Lightful in 2015 as the Director of Product and Marketing, where they played a key role in designing and delivering product and growth strategies.

Anna became a Fellow at The RSA in 2015 and held the position until 2020. At DrugScience Ltd, Anna served as the CMO from 2018 to 2019, leading the full rebranding of the charity and implementing an integrated growth tech stack.

In 2020, Anna served as an Independent Advisor at Drug Science. Most recently, they co-founded and served as the COO of Wavepaths from 2018 to 2022, building a well-known brand in the psychedelic space and leading commercial strategy and operations.

Throughout their career, Anna has demonstrated expertise in brand development, growth strategies, and organizational leadership.

Anna Wakefield attended the University of Oxford from 2007 to 2012, where they earned a Bachelor of Arts degree in Classics with a focus on Literae Humaniores. In addition to their degree, they obtained a certification as an Omnicom Emerging Star in 2015 through the institution of Omnicom. No specific month or year of attainment for the certification is provided.